» Articles » PMID: 32903457

Urine Metabolomics Study on Potential Hepatoxic Biomarkers Identification in Rats Induced by Aurantio-Obtusin

Overview
Journal Front Pharmacol
Date 2020 Sep 9
PMID 32903457
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

Previous studies revealed the hepatotoxic effect of aurantio-obtusin on rats. The aim of this study was to identify potential biomarkers of urine caused by aurantio-obtusin. Sprague-Dawley (SD) rats with body weight of 0, 4, 40, and 200 mg/kg were orally given aurantio-obtusin for 28 days, and urine was collected for 24 h after the last administration. The urine metabolites in the aurantio-obtusin group and the control group were analyzed by ultraperformance liquid chromatography quadrupole time-of-flight mass spectrometry (UPLC-QTOF/MS). Twenty-three metabolites were identified as potential biomarkers, and 10 of them were up-regulated, including xanthosine, hippuric acid, 5-L-glutamyl-taurine, etc. The other 13 biomarkers were down-regulated, including thymidine, 3-methyldioxyindole, cholic acid, etc. The significant changes of these biomarkers indicated that purine metabolism, taurine and hypotaurine metabolism, primary bile acid biosynthesis, pyrimidine metabolism, and tryptophan metabolism played an important role in the hepatotoxicity of aurantio-obtusin in rats. In this paper, the safety and potential risk of aurantio-obtusin were studied for the first time by combining the toxicity of aurantio-obtusin with the results of urine metabolomics, which provided information for the mechanism of liver injury induced by aurantio-obtusin.

Citing Articles

Distinct signatures of gut microbiota and metabolites in primary biliary cholangitis with poor biochemical response after ursodeoxycholic acid treatment.

Han W, Song T, Huang Z, Liu Y, Xu B, Huang C Cell Biosci. 2024; 14(1):80.

PMID: 38879547 PMC: 11180406. DOI: 10.1186/s13578-024-01253-1.


Gut microbes combined with metabolomics reveal the protective effects of Qijia Rougan decoction against CCl-induced hepatic fibrosis.

Li X, Xu X, Tao S, Su Y, Wen L, Wang D Front Pharmacol. 2024; 15:1347120.

PMID: 38606180 PMC: 11007057. DOI: 10.3389/fphar.2024.1347120.


Mechanism of the Effect of Compound . Oral Liquid in Treating Alcoholic Rat Liver Injury by Metabolomics.

Huang T, Wu Y, Huang L, Lin R, Li Z, Wang X Drug Des Devel Ther. 2023; 17:3409-3428.

PMID: 38024538 PMC: 10659148. DOI: 10.2147/DDDT.S427837.


Modulating gut microbiota and metabolites with dietary fiber oat β-glucan interventions to improve growth performance and intestinal function in weaned rabbits.

Ma L, Luo Z, Huang Y, Li Y, Guan J, Zhou T Front Microbiol. 2023; 13:1074036.

PMID: 36590438 PMC: 9798315. DOI: 10.3389/fmicb.2022.1074036.


Emerging biotechnology applications in natural product and synthetic pharmaceutical analyses.

Chen S, Li Z, Zhang S, Zhou Y, Xiao X, Cui P Acta Pharm Sin B. 2022; 12(11):4075-4097.

PMID: 36386468 PMC: 9643291. DOI: 10.1016/j.apsb.2022.08.025.


References
1.
Ogihara K, MOZAI T, Hirai S . Tryptophan as cause of hepatic coma. N Engl J Med. 1966; 275(22):1255-6. DOI: 10.1056/NEJM196612012752215. View

2.
Heubi J, Setchell K, Jha P, Buckley D, Zhang W, Rosenthal P . Treatment of bile acid amidation defects with glycocholic acid. Hepatology. 2014; 61(1):268-74. PMC: 4280294. DOI: 10.1002/hep.27401. View

3.
Li C, Tu C, Gao D, Wang R, Zhang H, Niu M . Metabolomic Study on Idiosyncratic Liver Injury Induced by Different Extracts of in Rats Integrated with Pattern Recognition and Enriched Pathways Analysis. Front Pharmacol. 2016; 7:483. PMC: 5156827. DOI: 10.3389/fphar.2016.00483. View

4.
Badr M, Ganey P, Yoshihara H, Kauffman F, Thurman R . Hepatotoxicity of menadione predominates in oxygen-rich zones of the liver lobule. J Pharmacol Exp Ther. 1989; 248(3):1317-22. View

5.
Teschke R, Frenzel C, Schulze J, Eickhoff A . Herbal hepatotoxicity: challenges and pitfalls of causality assessment methods. World J Gastroenterol. 2013; 19(19):2864-82. PMC: 3660812. DOI: 10.3748/wjg.v19.i19.2864. View